{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:05:47Z","timestamp":1789106747354,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00652-8","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:56Z","timestamp":1789103276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin-loaded invasomal gel: preparation, optimization, in vitro evaluation and ex vivo skin permeation evaluation"],"prefix":"10.1007","volume":"34","author":[{"given":"Janavi","family":"Sosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Pimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"652_CR1","unstructured":"Cancer [Internet]. [cited 2024 Jul 28]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer. Accessed 28 Jul 2024."},{"key":"652_CR2","unstructured":"Skin cancer [Internet]. [cited 2024 Jul 28]. https:\/\/www.aad.org\/media\/stats-skin-cancer. Accessed 28 Jul 2024."},{"key":"652_CR3","unstructured":"Lopez-Ojeda W, Pandey A, Alhajj M, Oakley AM. Anatomy, Skin (Integument). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. [updated 2023 Oct 17; cited 2025 May 31]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441980\/"},{"key":"652_CR4","unstructured":"Principles of Anatomy and Physiology -, Gerard J, Tortora BH. Derrickson - Google Books [Internet]. [cited 2025 May 31]. https:\/\/books.google.co.in\/books\/about\/Principles_of_Anatomy_and_Physiology.html?id=aSaVDwAAQBAJ&redir_esc=y. Accessed 31 May 2025."},{"key":"652_CR5","doi-asserted-by":"publisher","unstructured":"Proksch E, Brandner JM, Jensen JM. The skin: An indispensable barrier. Exp Dermatol. 2008;17(12):1063-72. https:\/\/doi.org\/10.1111\/J.1600-0625.2008.00786.X","DOI":"10.1111\/J.1600-0625.2008.00786.X"},{"key":"652_CR6","doi-asserted-by":"publisher","unstructured":"Supe S, Takudage P. Methods for evaluating penetration of drug into the skin: A review. Skin Res Technol. 2021;27(3):299-308. https:\/\/doi.org\/10.1111\/SRT.12968.","DOI":"10.1111\/SRT.12968"},{"key":"652_CR7","unstructured":"Melanoma Skin Cancer Risk Factors. | Melanoma Risk Factors | American Cancer Society [Internet]. https:\/\/www.cancer.org\/cancer\/types\/melanoma-skin-cancer\/causes-risks-prevention\/risk-factors.html. Accessed 28 Jul 2024."},{"key":"652_CR8","doi-asserted-by":"publisher","unstructured":"Bibi N, Ahmed N, Khan GM. Nanostructures in transdermal drug delivery systems. In: Andronescu E, Grumezescu AM, editors. Nanostructures for Drug Delivery. Elsevier; 2017. p. 639-68. https:\/\/doi.org\/10.1016\/B978-0-323-46143-6.00021-X","DOI":"10.1016\/B978-0-323-46143-6.00021-X"},{"key":"652_CR9","doi-asserted-by":"publisher","unstructured":"Gordon R. Skin cancer: An overview of epidemiology and risk factors. Semin Oncol Nurs. Semin Oncol Nurs. 2013;29:160\u20139. https:\/\/doi.org\/10.1016\/j.soncn.2013.06.002","DOI":"10.1016\/j.soncn.2013.06.002"},{"key":"652_CR10","unstructured":"Gruber P, Shah M, Zito PM. Skin Cancer. StatPearls. StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441949\/. Accessed 31 May 2025."},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2131\/JTS.25.3_181","volume":"25","author":"M Mori","year":"2000","unstructured":"Mori M, Kobayashi H, Sugiyama C, Katsumura Y, Furihata C. Effect of aging on unscheduled DNA synthesis induction by UV-B irradiation in hairless mouse epidermis. J Toxicol Sci [Internet] Japanese Soc Toxicol. 2000;25:181\u20138. https:\/\/doi.org\/10.2131\/JTS.25.3_181. [cited 2025 May 31];.","journal-title":"J Toxicol Sci [Internet] Japanese Soc Toxicol"},{"key":"652_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/ACEL.14422","author":"A Fotopoulou","year":"2024","unstructured":"Fotopoulou A, Angelopoulou MT, Pratsinis H, Mavrogonatou E, Kletsas D. A subset of human dermal fibroblasts overexpressing Cockayne syndrome group B protein resist UVB radiation-mediated premature senescence. Aging Cell [Internet] John Wiley Sons Inc. 2024. https:\/\/doi.org\/10.1111\/ACEL.14422. [cited 2025 May 31];24.","journal-title":"Aging Cell [Internet] John Wiley Sons Inc"},{"key":"652_CR13","doi-asserted-by":"publisher","unstructured":"Black APB, Ogg GS. The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol. 2003;132:379. https:\/\/doi.org\/10.1046\/J.1365-2249.2003.02159.X","DOI":"10.1046\/J.1365-2249.2003.02159.X"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0923-1811(01)00170-0","volume":"29","author":"MY Kim","year":"2002","unstructured":"Kim MY, Park HJ, Baek SC, Byun DG, Houh D. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci [Internet] J Dermatol Sci. 2002;29:1\u20139. https:\/\/doi.org\/10.1016\/S0923-1811(01)00170-0. [cited 2025 May 31];.","journal-title":"J Dermatol Sci [Internet] J Dermatol Sci"},{"key":"652_CR15","doi-asserted-by":"publisher","unstructured":"Eggermont AMM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014 Mar 1;383(9919):816-827. https:\/\/doi.org\/10.1016\/s0140-6736(13)60802-8","DOI":"10.1016\/s0140-6736(13)60802-8"},{"key":"652_CR16","unstructured":"Riml S, Larcher L, Surgery PK-A, of P. 2013 undefined. Complete excision of nonmelanotic skin cancer: a matter of surgical experience. Ann Plast Surg. 2013 https:\/\/journals.lww.com\/annalsplasticsurgery\/FullText\/2013\/01000\/Complete_Excision_of_Nonmelanotic_Skin_Cancer__A.16.aspx. Accessed 28 Jul 2024."},{"key":"652_CR17","unstructured":"Bittner G, Cerci F, \u2026 EK-AB, 2021 undefined. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. SciELO BrasilGC Bittner,FB Cerci, EM Kubo, SN TolkachjovAnais Brasileiros de Dermatologia, 2021\u2022SciELO Brasil[Internet].https:\/\/www.scielo.br\/j\/abd\/a\/ycwZBT6LqxS4mKHP6TMMTPd\/?format=html&lang=en. Accessed 28 Jul 2024"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/14737140.2015.1042865","volume":"15","author":"Y Rong","year":"2015","unstructured":"Rong Y, Zuo L, Shang L, Bazan JG. Radiotherapy treatment for nonmelanoma skin cancer. Expert Rev Anticancer Ther Expert Reviews Ltd. 2015;15:765\u201376. https:\/\/doi.org\/10.1586\/14737140.2015.1042865.","journal-title":"Expert Rev Anticancer Ther Expert Reviews Ltd"},{"key":"652_CR19","doi-asserted-by":"publisher","unstructured":"Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg. 2004;30(2 Pt 2):297-300. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30090.x","DOI":"10.1111\/j.1524-4725.2004.30090.x"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0733-8635(02)00022-0","volume":"20","author":"G Goldman","year":"2002","unstructured":"Goldman G. The current status of curettage and electrodesiccation. Dermatol Clin. 2002;20:569\u201378. https:\/\/doi.org\/10.1016\/S0733-8635(02)00022-0.","journal-title":"Dermatol Clin"},{"key":"652_CR21","doi-asserted-by":"publisher","unstructured":"Dhanalekshmi KI, Sangeetha K, Magesan P, Johnson J, Zhang X, Jayamoorthy K. Photodynamic cancer therapy: Role of Ag- and Au-based hybrid nano-photosensitizers. J Biomol Struct Dyn. 2022;40(10):4766-4773. https:\/\/doi.org\/10.1080\/07391102.2020.1858965","DOI":"10.1080\/07391102.2020.1858965"},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40425-018-0442-7\/TABLES\/4","volume":"6","author":"V Verma","year":"2018","unstructured":"Verma V, Sprave T, Haque W, Simone CB, Chang JY, Welsh JW, et al. A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. J Immunother Cancer [Internet] BioMed. 2018;6:1\u201315. https:\/\/doi.org\/10.1186\/S40425-018-0442-7\/TABLES\/4. [cited 2024 Dec 6];. Central Ltd.","journal-title":"J Immunother Cancer [Internet] BioMed"},{"key":"652_CR23","doi-asserted-by":"publisher","unstructured":"Gupta N, Gupta GD, Singh D. Localized topical drug delivery systems for skin cancer: Current approaches and future prospects. Front Nanotechnol. 2022 Oct 28;4:1006628 https:\/\/doi.org\/10.3389\/FNANO.2022.1006628\/XML\/NLM.","DOI":"10.3389\/FNANO.2022.1006628\/XML\/NLM"},{"key":"652_CR24","doi-asserted-by":"publisher","unstructured":"Chaurasiya M, Kumar G, Paul S, Verma SS, Rawal RK. Natural product-loaded lipid-based nanocarriers for skin cancer treatment: An overview. Life Sci. 2024;357:123043. https:\/\/doi.org\/10.1016\/j.lfs.2024.123043.","DOI":"10.1016\/j.lfs.2024.123043"},{"key":"652_CR25","doi-asserted-by":"publisher","unstructured":"Babaie S, Del Bakhshayesh AR, Ha JW, Hamishehkar H, Kim KH. Invasome: A novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020;10(2):341. https:\/\/doi.org\/10.3390\/NANO10020341.","DOI":"10.3390\/NANO10020341"},{"key":"652_CR26","doi-asserted-by":"publisher","unstructured":"Parikh DK, Ghosh TK. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech. 2005;6(2):E144-E149 https:\/\/doi.org\/10.1208\/PT060222","DOI":"10.1208\/PT060222"},{"key":"652_CR27","doi-asserted-by":"publisher","unstructured":"Cevc G, Sch\u00e4tzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta Biomembr. 2002;1564(1):21-30. https:\/\/doi.org\/10.1016\/s0005-2736(02)00401-7","DOI":"10.1016\/s0005-2736(02)00401-7"},{"key":"652_CR28","doi-asserted-by":"publisher","unstructured":"Dwivedi R, Bala R, Madaan R, Singh S, Sindhu RK. Terpene-based novel invasomes: Pioneering cancer treatment strategies in traditional medicine. J Complement Integr Med. 2024;22(1):1-14. https:\/\/doi.org\/10.1515\/JCIM-2024-0131\/MACHINEREADABLECITATION\/RIS","DOI":"10.1515\/JCIM-2024-0131\/MACHINEREADABLECITATION\/RIS"},{"key":"652_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118657","author":"OAA Ahmed","year":"2019","unstructured":"Ahmed OAA, Badr-Eldin SM. Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. Int J Pharm [Internet] Elsevier B V. 2019. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118657. [cited 2025 May 31];570.","journal-title":"Int J Pharm [Internet] Elsevier B V"},{"key":"652_CR30","doi-asserted-by":"publisher","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, et al. Therapeutic potential of quercetin: New insights and perspectives for human health. ACS Omega. 2020;5(21):11849-72. https:\/\/doi.org\/10.1021\/ACSOMEGA.0C01818","DOI":"10.1021\/ACSOMEGA.0C01818"},{"issue":"4","key":"652_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1124\/mol.104.008367","volume":"68","author":"JL Won","year":"2005","unstructured":"Won JL, Shim JY, Zhu BT. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol. 2005;68(4):1018\u201330. https:\/\/doi.org\/10.1124\/mol.104.008367","journal-title":"Mol Pharmacol"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mce.2016.04.024","volume":"431","author":"V Sharma","year":"2016","unstructured":"Sharma V, Kumar L, Mohanty SK, Maikhuri JP, Rajender S, Gupta G. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Mol Cell Endocrinol. 2016;431:12\u201323. https:\/\/doi.org\/10.1016\/j.mce.2016.04.024","journal-title":"Mol Cell Endocrinol"},{"key":"652_CR33","doi-asserted-by":"publisher","unstructured":"Zheng NG, Wang JL, Yang SL, Wu JL. Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-\u03baB signaling. Asian Pac J Cancer Prev. 2014;15(11):4539-43. https:\/\/doi.org\/10.7314\/APJCP.2014.15.11.4539.","DOI":"10.7314\/APJCP.2014.15.11.4539"},{"key":"652_CR34","doi-asserted-by":"publisher","unstructured":"Venza M, Visalli M, Biondo C, Lentini M, Catalano T, Teti D, et al. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma. Biochim Biophys Acta Gene Regul Mech. 2015;1849(3):247-56. https:\/\/doi.org\/10.1016\/J.BBAGRM.2014.12.004.","DOI":"10.1016\/J.BBAGRM.2014.12.004"},{"key":"652_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2173275","author":"E Schadich","year":"2016","unstructured":"Schadich E, Hlav\u00e1\u010d J, Voln\u00e1 T, Varanasi L, Hajd\u00fach M, D\u017eub\u00e1k P. Effects of Ginger Phenylpropanoids and Quercetin on Nrf2-ARE Pathway in Human BJ Fibroblasts and HaCaT Keratinocytes. Biomed Res Int [Internet] Hindawi Publishing Corporation. 2016. https:\/\/doi.org\/10.1155\/2016\/2173275. [cited 2025 May 31];2016.","journal-title":"Biomed Res Int [Internet] Hindawi Publishing Corporation"},{"key":"652_CR36","doi-asserted-by":"publisher","unstructured":"Chaiprasongsuk A, Onkoksoong T, Pluemsamran T, Limsaengurai S, Panich U. Photoprotection by dietary phenolics against melanogenesis induced by UVA through Nrf2-dependent antioxidant responses. Redox Biol. 2016;8:79-90. https:\/\/doi.org\/10.1016\/J.REDOX.2015.12.006","DOI":"10.1016\/J.REDOX.2015.12.006"},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cbi.2011.12.005","volume":"195","author":"AB Granado-Serrano","year":"2012","unstructured":"Granado-Serrano AB, Mart\u00edn MA, Bravo L, Goya L, Ramos S. Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38. Chem Biol Interact [Internet] Chem Biol Interact. 2012;195:154\u201364. https:\/\/doi.org\/10.1016\/j.cbi.2011.12.005. [cited 2025 May 31];.","journal-title":"Chem Biol Interact [Internet] Chem Biol Interact"},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2010.09.020","volume":"649","author":"R Vidya Priyadarsini","year":"2010","unstructured":"Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-\u03baB inhibition. Eur J Pharmacol [Internet] Eur J Pharmacol. 2010;649:84\u201391. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.020. [cited 2025 May 31];.","journal-title":"Eur J Pharmacol [Internet] Eur J Pharmacol"},{"key":"652_CR39","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/01635581.2013.810291","volume":"65","author":"E Pozsgai","year":"2013","unstructured":"Pozsgai E, Bellyei S, Cseh A, Boronkai A, Racz B, Szabo A, et al. Quercetin increases the efficacy of glioblastoma treatment compared to standard chemoradiotherapy by the suppression of PI-3-kinase-akt pathway. Nutr Cancer [Internet] Nutr Cancer. 2013;65:1059\u201366. https:\/\/doi.org\/10.1080\/01635581.2013.810291. [cited 2025 May 31];.","journal-title":"Nutr Cancer [Internet] Nutr Cancer"},{"key":"652_CR40","doi-asserted-by":"publisher","unstructured":"Ang LF, Yam MF, Fung YTT, Kiang PK, Darwin Y. HPLC method for simultaneous quantitative detection of quercetin and curcuminoids in Traditional Chinese Medicines. J Pharmacopuncture. 2014;17(4):36-49. https:\/\/doi.org\/10.3831\/KPI.2014.17.035","DOI":"10.3831\/KPI.2014.17.035"},{"key":"652_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.31254\/phyto.2021.10401","volume":"10","author":"P Garg","year":"2021","unstructured":"Garg P. HPLC Estimation of Flavanoid (quercetin) of leaves and stem extracts of Ocimum sanctum and Tinospora cordifolia. J Phytopharmacology. 2021;10:220\u20134. https:\/\/doi.org\/10.31254\/phyto.2021.10401","journal-title":"J Phytopharmacology [Internet]"},{"key":"652_CR42","doi-asserted-by":"publisher","unstructured":"Samir B, El-Kamel A, Zahran N, Heikal L. Resveratrol-loaded invasome gel: A promising nanoformulation for treatment of skin cancer. Drug Deliv Transl Res. 2024;14(12):3354-70. https:\/\/doi.org\/10.1007\/S13346-024-01534-9\/FIGURES\/10","DOI":"10.1007\/S13346-024-01534-9\/FIGURES\/10"},{"key":"652_CR43","doi-asserted-by":"publisher","unstructured":"Tawfik MA, Tadros MI, Mohamed MI, El-Helaly SN. Low-frequency versus high-frequency ultrasound-mediated transdermal delivery of agomelatine-loaded invasomes: Development, optimization and in-vivo pharmacokinetic assessment. Int J Nanomedicine. 2020;15:8893-8910. https:\/\/doi.org\/10.2147\/IJN.S283911","DOI":"10.2147\/IJN.S283911"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"105659","DOI":"10.1016\/j.jddst.2024.105659","volume":"96","author":"MA Kalam","year":"2024","unstructured":"Kalam MA, Ali R, Alhowyan A, Ahmad A, Iqbal M, Raish M. Quercetin-loaded transliposomal gel for effective management of skin cancer: In vitro and cell line efficacy studies. J Drug Deliv Sci Technol. 2024;96:105659. https:\/\/doi.org\/10.1016\/j.jddst.2024.105659","journal-title":"J Drug Deliv Sci Technol"},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"109984","DOI":"10.1016\/j.biopha.2020.109984","volume":"125","author":"D Peng","year":"2020","unstructured":"Peng D, Chen L, Sun Y, Sun L, Yin Q, Deng S, et al. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling. Biomed Pharmacother. 2020;125:109984. https:\/\/doi.org\/10.1016\/j.biopha.2020.109984","journal-title":"Biomed Pharmacother"},{"key":"652_CR46","doi-asserted-by":"publisher","unstructured":"Fong Yen W, Basri M, Ahmad M, Ismail M. Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system. Sci World J. 2015;2015:495271. https:\/\/doi.org\/10.1155\/2015\/495271","DOI":"10.1155\/2015\/495271"},{"key":"652_CR47","unstructured":"Formulation of nanostructured based delivery system of fiset in for skin cancer. Int J Pharm Sci Res. https:\/\/ijpsr.com\/bft-article\/formulation-of-nanostructured-based-delivery-system-of-fiset-in-for-skin-cancer\/. Accessed 19 Jun 2025"},{"key":"652_CR48","doi-asserted-by":"publisher","first-page":"105150","DOI":"10.1016\/j.tiv.2021.105150","volume":"74","author":"P Budai","year":"2021","unstructured":"Budai P, Kormos \u00c9, Buda I, Somody G, Lehel J. Comparative evaluation of HET-CAM and ICE methods for objective assessment of ocular irritation caused by selected pesticide products. Toxicol Vitro. 2021;74:105150. https:\/\/doi.org\/10.1016\/j.tiv.2021.105150","journal-title":"Toxicol Vitro"},{"key":"652_CR49","unstructured":"ICCVAM-Recommended Test Method Protocol: Hen\u2019s Egg Test-Chorioallantoic Membrane (HET-CAM) Test Method. [cited 2025 Jun 19]. http:\/\/iccvam.niehs.nih.gov\/methods\/ocutox\/MildMod-TMER.htm.\u00a0Accessed 19 Jun 2025"},{"issue":"1","key":"652_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/s0103-64402012000100004","volume":"23","author":"EJ de Garcia","year":"2012","unstructured":"Garcia EJ, Cadorin Oldoni TL, de Alencar SM, Reis A, Loguercio AD, Miranda Grande RH. Antioxidant activity by DPPH assay of potential solutions to be applied on bleached teeth. Braz Dent J. 2012;23(1):22\u20137. https:\/\/doi.org\/10.1590\/s0103-64402012000100004","journal-title":"Braz Dent J"},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijpharm.2019.01.067","volume":"560","author":"T Moolakkadath","year":"2019","unstructured":"Moolakkadath T, Aqil M, Ahad A, Imam SS, Praveen A, Sultana Y, et al. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Int J Pharm. 2019;560:78\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.067","journal-title":"Int J Pharm"},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"105252","DOI":"10.1016\/j.jddst.2023.105252","volume":"91","author":"G Vambhurkar","year":"2024","unstructured":"Vambhurkar G, Famta P, Shah S, Jain N, Srinivasarao DA, Sharma A, et al. Quality by Design Galvanized development of resveratrol loaded PLGA nanoparticles: In vitro and Ex vivo evaluation for the non-invasive treatment of metastatic melanoma. J Drug Deliv Sci Technol. 2024;91:105252. https:\/\/doi.org\/10.1016\/j.jddst.2023.105252","journal-title":"J Drug Deliv Sci Technol"},{"key":"652_CR53","doi-asserted-by":"publisher","unstructured":"Imran M, Iqubal MK, Imtiyaz K, Saleem S, Mittal S, Rizvi MMA, et al. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int J Pharm. 2020;587 https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119705","DOI":"10.1016\/j.ijpharm.2020.119705"},{"key":"652_CR54","doi-asserted-by":"publisher","first-page":"e0167172","DOI":"10.1371\/journal.pone.0167172","volume":"11","author":"L Dai","year":"2016","unstructured":"Dai L, Sun C, Wang D, Gao Y. The interaction between zein and lecithin in ethanol-water solution and characterization of zein\u2013lecithin composite colloidal nanoparticles. PLoS ONE. 2016;11:e0167172. https:\/\/doi.org\/10.1371\/journal.pone.0167172","journal-title":"PLoS ONE"},{"key":"652_CR55","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s12247-023-09732-7","volume":"18","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Salama AA, Gaber MH, Ali SA. Development and characterization of soy lecithin liposome as potential drug carrier systems for doxorubicin. J Pharm Innov. 2023;18:1415\u201326. https:\/\/doi.org\/10.1007\/s12247-023-09732-7","journal-title":"J Pharm Innov"},{"key":"652_CR56","unstructured":"Sujatha S, Sowmya G, Chaitanya M, Reddy VSK, Monica M, Kumar KK. Preparation, characterization and evaluation of finasteride ethosomes. Int J Drug Deliv. 2016;8(1):1-11. . https:\/\/ijdd.arjournals.org\/index.php\/ijdd\/article\/view\/287. Accessed 3 Jul 2025"},{"key":"652_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8896455","volume":"2020","author":"MT Vu","year":"2020","unstructured":"Vu MT, Le NTT, Pham TL-B, Nguyen NH, Nguyen DH. Development and characterization of soy lecithin liposome as potential drug carrier systems for codelivery of letrozole and paclitaxel. J Nanomater. 2020;2020:1\u20139. https:\/\/doi.org\/10.1155\/2020\/8896455","journal-title":"J Nanomater"},{"key":"652_CR58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13346-023-01412-w","volume":"14","author":"AG Fouad","year":"2024","unstructured":"Fouad AG, Ali MRA, Naguib DM, Farouk HO, Zanaty MI, El-Ela FIA. Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis. Drug Deliv Transl Res. 2024;14:474\u201390. https:\/\/doi.org\/10.1007\/s13346-023-01412-w","journal-title":"Drug Deliv Transl Res"},{"key":"652_CR59","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molliq.2018.06.085","volume":"266","author":"SM de Carvalho","year":"2018","unstructured":"Carvalho SM, Mansur AAP, Capanema NSV, Carvalho IC, Chagas P, de Oliveira LCA, et al. Synthesis and in vitro assessment of anticancer hydrogels composed by carboxymethylcellulose-doxorubicin as potential transdermal delivery systems for treatment of skin cancer. J Mol Liq. 2018;266:425\u201340. https:\/\/doi.org\/10.1016\/j.molliq.2018.06.085","journal-title":"J Mol Liq"},{"issue":"3","key":"652_CR60","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1208\/s12249-009-9299-x","volume":"10","author":"I \u00d6zcan","year":"2009","unstructured":"\u00d6zcan I, Abaci \u00d6, Uztan AH, Aksu B, Boyacio\u01e7lu H, G\u00fcneri T, et al. Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels. AAPS PharmSciTech. 2009;10(3):1024\u201331. https:\/\/doi.org\/10.1208\/s12249-009-9299-x","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"652_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/APP.35414;REQUESTEDJOURNAL:JOURNAL:10974628;PAGE:STRING:ARTICLE\/CHAPTER","volume":"125","author":"J Hurler","year":"2012","unstructured":"Hurler J, Engesland A, Poorahmary Kermany B, \u0160kalko-Basnet N. Improved texture analysis for hydrogel characterization: Gel cohesiveness, adhesiveness, and hardness. J Appl Polym Sci. 2012;125(1):180\u20138. https:\/\/doi.org\/10.1002\/APP.35414;REQUESTEDJOURNAL:JOURNAL:10974628;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"J Appl Polym Sci"},{"key":"652_CR62","doi-asserted-by":"publisher","unstructured":"El-Masry SM, Helmy SA Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles. Saudi Pharm J. 2020;28:1704\u201318. https:\/\/doi.org\/10.1016\/j.jsps.2020.10.016","DOI":"10.1016\/j.jsps.2020.10.016"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00652-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:08:00Z","timestamp":1789103280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00652-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00652-8","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"74"}}